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Background/Significance
Monodisperse iron oxide nanoparticles (MION) are easily synthesized in 
organic solvents for industrial applications.  However, biological 
applications require that the particles by readily dispersed in aqueous 
solutions. To improve their dispersion in aqueous solution, MION particles 
can be conjugated to water soluble polymers.  These water soluble 
particles can then be used for nanomedicine, which utilizes nanometer 
scale constructs to treat diseases at the cellular level.   Here we report the 
synthesis of a monodisperse iron oxide nanoparticle construct for breast 
cancer applications. 
Materials and Methods
Chemical synthesis
Monodisperse iron oxide nanoparticle (MION) synthesis
All nanoparticle synthesis reagents were purchased from Sigma-Aldrich (St. 
Louis, MO).  Chloroform and acetone were obtained from Mallinckrodt Baker 
(Phillipsburg, NJ).  MION particles were synthesized using oleic acid as a 
surfactant to keep the particles from aggregating (Figure 1). 2mmols iron 
oxide hydroxide FeOOH, 10mmols oleic acid, and 10.0g 1-octadecene were 
weighed out into a 250mL three-neck flask.  This suspension was subject to 
magnetic stirring under nitrogen atmosphere while heating to 320oC using a 
heating mantle and temperature controller.  This solution was allowed to reflux 
for 2 hrs and then cooled to room temperature before purification.  
Excess oleic acid and unreacted FeOOH were removed by extracting the 
nanoparticle suspension 3x with a 1:1 (v/v) methanol:chloroform solution.  
Acetone was then used to precipitate the nanoparticles from the octadecene 
phase.  The nanoparticles were then isolated using a 0.5T magnet and 
redispersed in chloroform.
Poly (maleic anhydride-alt-1-octadecene) (PMAO)-co-poly 
(ethylene glycol) (PEG) (PMAO-PEG) synthesis and conjugation 
to MION
PMAO-PEG was synthesized by combining PMAO and methoxy PEG in a 
1:30 molar ratio and refluxing in chloroform at 60oC for 18 hrs under nitrogen 
atmosphere using a few drops of sulfuric acid as catalyst (Figure 2).  
Chloroform was removed from the polymer by rotary evaporation.  
MION particles were then reacted with PMAO-PEG in chloroform for 24hrs 
using an approximate 1:10 molar ratio.    The resulting PMAO-PEG coated 
nanoparticles were then made water soluble by adding an equal volume of 
water as there was chloroform present and slowly evaporating the chloroform 
by rotary evaporation.  The nanoparticle suspension in water was then 
dialyzed against phosphate buffered saline (PBS) using 3,500 MWCO dialysis 
tubing to remove trace chloroform and to enhance its solubility in PBS.  The 
particle suspension in PBS was then dried in a vacuum oven overnight at 
room temperature and then resuspended at 1mg/mL in PBS.  
Characterization of MION and PMAO-PEG coated 
MION
Transmission electron microscopy (TEM)
High-energy TEM was utilized to measure the average diameter of MION 
particles as well as to evaluate particle dispersity and morphology.  MION 
particles in chloroform were added to acetone.  This dilute suspension was 
sonicated briefly and deposited onto holey carbon TEM grids. An FEI Titan 
80/300 field emission electron microscope (FEI Company, Hillsboro, OR) was 
used for TEM imaging. ImageJ™ software (NIH, Bethesda, MD) was used to 
identify and analyze MION particles present in TEM micrographs.
Atomic force microscopy (AFM)
AFM was performed on MION particles as a complementary technique to TEM 
to evaluate particle diameters and morphology. AFM samples were prepared 
by applying a suspension of MION particles in water to a freshly cleaved 3-
aminopropyltrimethoxysilane (APTMS)-functionalized mica substrate, drying 
the substrate, and imaging it in air in tapping mode AFM using silicon 
OTESPA probes (Veeco Probes, Camarillo, CA) with nominal tip radius of 
10nm, nominal spring constant of 42N/m, and resonance frequency of 
351kHz.  A BioScope II AFM (Veeco Instruments, Santa Barbara, CA) was 
used for this work. Nanoscope 6.13b26 software (Digital Instruments/Veeco) 
was used to display and analyze all AFM data.
Fourier transform infrared spectroscopy (FTIR)
FTIR samples of PMAO and PMAO-PEG polymers as well as MION particles 
were prepared by dissolving each separately in chloroform and then 
depositing the solutions onto the KBr aperture of Real Crystal® IR sample 
cards. PMAO-PEG coated MION particles were prepared similarly after 
dissolution in PBS. The solutions were then dried to form thin films prior to 
acquiring FTIR spectra using a Thermo Nicolet FTIR spectrometer.
Dynamic light scattering (DLS)
DLS was performed using a DynaPro99 (Wyatt Technology Corp., Santa 
Barbara, CA) dynamic light scattering instrument.  Dilute suspensions of 
MION particles in chloroform and PMAO-PEG coated MION particles in PBS 
were briefly sonicated before analysis.  The polymer coated particles were 
additionally filtered using a 0.22µm syringe filter.  A 2s acquisition time was 
used and the temperature was maintained at 22oC for all samples.  At least 30 
measurements were collected for each sample and data was analyzed using 
Dynamics v5.26.60 (Wyatt Technology Corp.). 
Results
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Figure 1. Reaction scheme for MION synthesis using iron oxide hydroxide as 
the iron source and oleic acid as organic surfactant.
Figure 2. Reaction scheme for PMAO-PEG synthesis.
Figure 3. TEM micrograph of 
MION particles deposited from 
acetone onto a holey carbon 
TEM grid.
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Figure 4. Particle size distribution for 
MION particles identified in TEM 
micrographs.
Figure 5. AFM tapping mode 
height image of MION particles 
dried onto an APTMS-
functionalized mica substrate. 
Scan size=1.5µm, scan 
rate=1.15Hz, z-range=14nm.
Figure 6. Cross section analysis of 
selected particles identified in Figure 5. 
Observed particle diameters were 58nm, 
64nm, and 93nm for particles bounded 
by blue, red, and green brackets, 
respectively. 
Figure 7. DLS particle size 
distribution for MION particles  
dispersed in chloroform 
(Rh=13.22nm +/- 4.47nm 
(polydispersity =33.8%) based 
on mass distribution. 
TEM micrographs indicated that the MION particles were monodisperse with 
a narrow size distribution and near spherical morphology (Figure 3).  
Analysis of 313 particles present in TEM micrographs indicate an average 
particle diameter of 18nm +/- 3nm (Figure 4).
AFM images of the MION particles also indicated a near spherical particle 
morphology (Figure 5).  As seen in Figure 6, cross section analysis was 
performed on the MION particles identified in Figure 5.  The diameters 
determined by this analysis are greater than those measured by TEM, likely 
due to convolution of the cantilever tip with the MION particles. 
Hydrodynamic radii (Rh) of MION particles, calculated by DLS via the 
Stokes-Einstein equation, were generally greater than those measured by
TEM  because Rh values are a measure of the radius of a theoretical 
dynamic hard sphere hydrated by water molecules and solvent ions. 
Uncoated MION particles dispersed in chloroform were found to have an 
average Rh value of 13.2nm +/- 4.5nm, corresponding to an average 
26.4nm diameter +/- 4.5nm) (Figure 7).  PMAO-PEG coated MION particles 
dispersed in PBS (Rh=33.9nm +/- 3.9nm, diameter=67.8nm +/- 7.8nm) had 
greater Rh values as expected due to the polymer coating (Figure 8).  The 
second particle population with Rh=150.2 indicates that some particle 
aggregation is occurring.  
Figure 8. Figure 7. DLS particle 
size distribution for PMAO-PEG 
coated MION particles  in PBS 
(Rh=33.9nm +/- 3.9nm, 
polydispersity =11.6%) based on 
mass distribution. 
Future Work
Peptide conjugation for cell targeting/enhanced particle 
uptake in specific cell types
Peptide conjugation to PMAO-PEG coated MION particles is planned to 
target the nanoparticle constructs to specific breast cancer cell types for 
more efficient nanoparticle dosing to cells.  Peptides with free amino 
groups can be directly conjugated to the free carboxyl groups present in 
PMAO-PEG that were created by maleic anhydride ring opening.  
Alternately, the free PMAO-PEG carboxyl groups could be first conjugated 
to a diamine linker and then a peptide containing free carboxyl groups 
could be conjugated to the nanoparticles via this linker molecule.  
DNA barcoding of PMAO-PEG MION for in vitro and in vivo
particle detection
Because iron oxide nanoparticles are difficult to detect in vitro owing to 
their extreme small size, the 26-mer oligonucleotide:
5’-GTGAAGCGTCAAACGACAATCGAACG-3’
(non-endogenous to the mouse or human genomes) will be conjugated to 
PMAO-PEG coated MION particles.  Its unique nucleotide sequence will 
allow the nanoparticle constructs to be recovered from tissue samples and 
detected by PCR amplification and subsequent DNA sequencing of the 
oligonucleotide “bar codes”.  This methodology is expected to be more 
definitive for detecting nanoparticles in-vitro than Prussian blue staining.  
AFM imaging of PMAO-PEG MION internalization
Real-time nanoparticle trafficking into breast cancer cells will be monitored 
by performing AFM on cells incubated in the presence of PMAO-PEG 
MION particles for various time periods.  Because it may be difficult to 
discern nanoparticles on cell surfaces by traditional AFM, magnetic force 
microscopy (MFM) will be used for this work.  MFM utilizes a cantilever 
with a magnetic tip that interacts with magnetic materials.  
Figure 9. FTIR spectra of PMAO (red trace) and PMAO-PEG (blue 
trace).  Band assignments: 1100= ―CH2―O― of methoxy PEG, 
1740=free COOH groups in PMAO-PEG resulting from PMAO anhydride 
ring opening, 1775=intact maleic anhydride C=O bond, 2850, 2920=C―H 
bonds present in CH2 groups of both polymers.
FTIR spectra obtained for PMAO and PMAO-PEG indicate that some 
PMAO-PEG was formed during the synthesis reaction (Figure 9).  Of 
particular interest in the spectra are two peaks.  The band at 1740 cm-1 , 
which is expected to be greater in magnitude for PMAO-PEG than for 
PMAO, corresponds to free carboxyl groups that result from maleic 
anhydride ring opening during the reaction.  The band at 1775 cm-1 should 
become less intense during the reaction and corresponds to the 
disappearance of the anhydride ring.  Although the disappearance of the 
anhydride ring is observed for the PMAO-PEG product, the resultant 
appearance of free carboxyl groups is not evident.  However, the band at 
1740 cm-1 is expected to become greater in intensity once water is 
introduced to PMAO-PEG.  
Conclusions
Synthesized monodisperse iron oxide nanoparticles had a narrow size 
distribution due to the transfer from octadecene to PBS solvent by coating 
with the ampiphilic copolymer PMAO-PEG. The PMAO unit has a 
hydrophobic octadecene side chain for interacting with the oleic acid 
surfactant on the MION surface and provides for a free carboxyl functional 
group for further conjugation to biomolecules including peptides and 
nucleic acids.  The PEG unit enhances the solubility of these MION in 
aqueous solutions.  Preliminary studies with Prussian Blue staining show 
that even uncoated MION can be taken up successfully by cells, while 
PEG-coated MION appear to be non-cytotoxic (99% viability reported). 
These nanoparticles have the potential for use in biological systems 
although long-term cytotoxicity studies are needed.   
Cell culture and Prussian blue staining
MDA-MB-231 breast cancer cells were obtained from the American Type 
Culture Collection (ATCC) (Manassas, VA), cultured using RPMI-1640 
medium (ATCC) adjusted to contain 10% (v/v) Fetalplex (Gemini 
Bioproducts, West Sacramento, CA), and incubated at 37°C with 5% CO2 for 
5 hrs. PMAO-PEG coated MION particles were then added to cells at final 
concentrations of 0.005mg/mL, 0.01mg/mL, 0.02mg/mL, 0.05mg/mL, and 
0.1mg/mL.  After 1hr nanoparticle exposure, the cells were stained with 2% 
potassium ferrocyanide in 6% HCl in PBS for 30 min in the dark . The cells 
were then harvested by trypsinization, fixed in 4% glutaraldehyde in PBS, 
and imaged using a Nikon (Nikon, Melville, NY) Optiphot inverted
fluorescence microscope in brightfield mode under 20x and 40x 
magnification.  
Prussian blue staining of MDA-MB-231 breast cancer cells exposed to 
various concentrations (5-100µg/mL) PMAO-PEG coated MION particles 
was done to determine the particle concentration that qualitatively showed 
particle uptake in cells. Prussian Blue staining is intended to result in a 
blue coloration of any iron-containing compounds in cell populations, 
including MION particles and endogenous iron. With the first experiment, 
it was difficult to ascertain by this method whether any MION particles 
were taken up by the cells (data not shown).  The cells were, however, 
99% viable after 1hr PMAO-PEG MION exposure. Previous studies 
showed very intense coloration of the cells after uptake of non-coated 
MION (Figure 10). 
Figure 10. Brightfield 
microscopy image of 
Prussian blue stained cells 
after 2hr exposure to non-
coated MION particles.
